Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Receives Consensus Rating of “Moderate Buy” from Brokerages

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) has earned an average recommendation of “Moderate Buy” from the six analysts that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, three have given a buy rating and one has issued a strong buy rating on the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $17.00.

SENS has been the topic of several recent analyst reports. Stifel Nicolaus cut their price target on shares of Senseonics Holdings, Inc. Common Stock from $9.00 to $8.00 and set a “hold” rating on the stock in a report on Monday, May 11th. Weiss Ratings initiated coverage on shares of Senseonics Holdings, Inc. Common Stock in a report on Tuesday, February 17th. They issued a “sell (d-)” rating for the company. Finally, HC Wainwright dropped their target price on shares of Senseonics Holdings, Inc. Common Stock from $18.50 to $14.00 and set a “buy” rating for the company in a research report on Tuesday, May 12th.

Insider Transactions at Senseonics Holdings, Inc. Common Stock

In other news, CEO Timothy T. Goodnow acquired 17,225 shares of the business’s stock in a transaction on Friday, March 13th. The shares were acquired at an average cost of $5.79 per share, with a total value of $99,732.75. Following the transaction, the chief executive officer owned 651,243 shares in the company, valued at $3,770,696.97. The trade was a 2.72% increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Douglas A. Roeder bought 22,686 shares of Senseonics Holdings, Inc. Common Stock stock in a transaction on Tuesday, May 12th. The shares were purchased at an average price of $5.56 per share, for a total transaction of $126,134.16. Following the acquisition, the director directly owned 144,635 shares in the company, valued at approximately $804,170.60. This trade represents a 18.60% increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last three months, insiders purchased 57,411 shares of company stock valued at $326,142. 4.70% of the stock is owned by insiders.

Institutional Investors Weigh In On Senseonics Holdings, Inc. Common Stock

Several hedge funds have recently made changes to their positions in the company. Ausdal Financial Partners Inc. raised its holdings in Senseonics Holdings, Inc. Common Stock by 50.0% in the third quarter. Ausdal Financial Partners Inc. now owns 105,000 shares of the company’s stock worth $46,000 after purchasing an additional 35,000 shares in the last quarter. GSK plc bought a new stake in shares of Senseonics Holdings, Inc. Common Stock during the 4th quarter valued at $60,000. Townsend Asset Management Corp NC ADV purchased a new stake in shares of Senseonics Holdings, Inc. Common Stock in the 4th quarter worth about $60,000. Kestra Advisory Services LLC purchased a new stake in shares of Senseonics Holdings, Inc. Common Stock in the 1st quarter worth about $68,000. Finally, Sanctuary Advisors LLC bought a new position in shares of Senseonics Holdings, Inc. Common Stock in the 4th quarter worth about $71,000. 12.36% of the stock is currently owned by institutional investors.

Senseonics Holdings, Inc. Common Stock Stock Performance

NASDAQ SENS opened at $6.72 on Friday. The stock has a market cap of $280.90 million, a PE ratio of -3.36 and a beta of 1.05. Senseonics Holdings, Inc. Common Stock has a fifty-two week low of $4.79 and a fifty-two week high of $12.58. The stock has a 50 day simple moving average of $6.39. The company has a current ratio of 3.51, a quick ratio of 3.19 and a debt-to-equity ratio of 1.05.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) last posted its earnings results on Thursday, May 7th. The company reported ($0.71) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.65) by ($0.06). The business had revenue of $11.71 million for the quarter. Senseonics Holdings, Inc. Common Stock had a negative net margin of 213.87% and a negative return on equity of 129.97%. Sell-side analysts predict that Senseonics Holdings, Inc. Common Stock will post -2.38 earnings per share for the current year.

Senseonics Holdings, Inc. Common Stock Company Profile

Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.

Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.